CLVLY Stock Price, Chart, Stats & News
Clinuvel Pharmaceuticals Limited (CLVLY) is a dividend-paying stock with a current dividend yield of 0.48% as of Aug 14, 2026. It pays $0.0329 per share over the trailing twelve months and distributes annually. Its dividend has grown at a 12.85% 5-year compound annual rate.
Dividend safety
Dividend coverage looks healthy — CLVLY pays out about 7% of earnings.
CLVLY chart
About
Clinuvel Pharmaceuticals Limited is a biopharmaceutical firm dedicated to creating and marketing therapies for individuals worldwide grappling with genetic, metabolic, and severe medical conditions, operating across Australia, Europe, the United States, and Switzerland. Their flagship therapeutic, SCENESSE, is a systemic photoprotective medication designed to shield adult patients suffering from erythropoietic protoporphyria (EPP) from light-induced damage. The company's development portfolio also features CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which stimulates extended cellular activity; and PRÉNUMBRA, an injectable liquid form of afamelanotide.
Related lists
Similar securities
Based on sector and market capitalization
